Other
Net Change in Cash
Year-over-year, this metric grew by 103.1%, from -$2.07B to $65.00M. Over 3 years (FY 2022 to FY 2025), Net Change in Cash shows a downward trend with a 230.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
Metric ID:
net_change_in_cashHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $828.00M | -$531.00M | -$1.04B | $443.00M | -$40.00M | $713.00M | -$476.00M | $768.00M | $1.00M | $380.00M | -$1.37B | -$1.95B | $2.26B | $4.96B | -$2.07B | -$2.78B | $2.19B | $0.00 | $65.00M |
| QoQ Change | — | -164.1% | -96.2% | +142.5% | -109.0% | >999% | -166.8% | +261.3% | -99.9% | >999% | -459.7% | -42.4% | +216.3% | +118.9% | -141.7% | -34.8% | +178.6% | -100.0% | — |
| YoY Change | — | — | — | -46.5% | +92.5% | — | +54.3% | +73.4% | +102.5% | -46.7% | -187.2% | -353.4% | >999% | >999% | -51.1% | -43.0% | -3.4% | -100.0% | +103.1% |
Range-$2.78B – $4.96B
CAGR-43.2%
Avg YoY Growth>999%
Median YoY Growth-3.4%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's net change in cash?
- Gilead Sciences (GILD) reported net change in cash of $65.00M in Q1 2026.
- How has Gilead Sciences's net change in cash changed year-over-year?
- Gilead Sciences's net change in cash increased by 103.1% year-over-year, from -$2.07B to $65.00M.
- What is the long-term trend for Gilead Sciences's net change in cash?
- Over 3 years (2022 to 2025), Gilead Sciences's net change in cash has grown at a 230.1% compound annual growth rate (CAGR), from $74.00M to -$2.66B.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.